Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?

Purpose of Review To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. Recent Findings The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing cont...

Full description

Saved in:
Bibliographic Details
Published in:Current HIV/AIDS reports 2018-06, Vol.15 (3), p.266-275
Main Authors: Rich, Katherine M., Bia, Joshua, Altice, Frederick L., Feinberg, Judith
Format: Article
Language:English
Subjects:
Drug addiction
Drug delivery
Hepatitis C
HIV
Human immunodeficiency virus
Medicine
Medicine & Public Health
Narcotics
Opioids
Prophylaxis
Section Editor
The Global Epidemic (SH Vermund
The Global Epidemic (SH Vermund, Section Editor)
Topical Collection on The Global Epidemic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of Review To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. Recent Findings The design and scale-up of multidisciplinary care models that engage, retain, and treat individuals with HIV, HCV, and OUD are critical to preventing continued spread of HIV and HCV. We identified 17 models within primary care ( N  = 3), HIV specialty care ( N  = 5), opioid treatment programs ( N  = 6), transitional clinics ( N  = 2), and community-based harm reduction programs ( N  = 1), as well as two emerging models. Summary Key components of such models are the provision of (1) medication-assisted treatment for OUD, (2) HIV and HCV treatment, (3) HIV pre-exposure prophylaxis, and (4) behavioral health services. Research is needed to understand differences in effectiveness between co-located and fully integrated care, combat the deleterious racial and ethnic legacies of the “War on Drugs,” and inform the delivery of psychiatric care. Increased access to harm reduction services is crucial.
ISSN:1548-3568
1548-3576
DOI:10.1007/s11904-018-0396-x